While the majority of basal cell carcinomas are triggered by cumulative exposure to ultraviolet radiation, these tumours can also develop within areas of skin that have been previously injured or scarred. This clinical phenomenon, although less common than sun-induced lesions, is a recognised factor in dermatology. The altered cellular environment and chronic inflammation associated with long-standing scars can sometimes provide a foundation for malignant changes to occur. Understanding the relationship between prior skin trauma and the development of cancer is an essential part of maintaining a comprehensive approach to long-term skin health in the United Kingdom.
What We’ll Discuss in This Article
- The biological mechanism of tumour development in scar tissue
- Identifying basal cell carcinoma in old surgical or injury scars
- The role of chronic inflammation in triggering malignant changes
- Recognising Marjolin ulcers and their clinical characteristics
- Why diagnosis is often delayed in areas of prior skin trauma
- Monitoring long-term scars for subtle changes in texture or appearance
The biological link between scars and skin cancer
The development of basal cell carcinoma in a scar is often related to the unique environment created during the healing process of a significant injury. When the skin is severely damaged, the normal structure of the dermis and epidermis is replaced by fibrous scar tissue. This tissue lacks the complex organisation of healthy skin and often has a reduced blood supply and altered immune surveillance. Over many years, these factors can make the cells within or at the edges of the scar more susceptible to the mutations that lead to cancer.
The National Health Service explains that while sun exposure is the primary cause of non-melanoma skin cancer, these tumours can occasionally develop in areas of the skin that have been damaged by previous injury or chronic inflammation. This can include scars from old burns, sites of previous radiotherapy, or even areas affected by long-term inflammatory skin conditions. The latent period between the initial injury and the appearance of the cancer can be very long, often spanning several decades.
Identifying BCC in old surgical or injury scars
When a basal cell carcinoma develops in a scar, it may not initially look like the typical pearly bump found on sun-exposed skin. Instead, it might appear as a subtle thickening of the scar tissue or a change in the scars colour or texture. Because the skin in a scar is already different from the surrounding area, these early changes can be very difficult to identify. The lesion might look like a small, firm nodule or a flat, scaly patch that slowly expands beyond the original borders of the scar.
A significant warning sign is when a previously stable scar begins to break down or ulcerate without a clear cause. If an old scar starts to bleed, itch, or develop a persistent sore that does not heal with standard wound care, it requires a professional clinical review. This is particularly important for scars located on the face, scalp, or limbs, where the skin is already under more environmental stress. Because of the pre-existing scar tissue, these tumours can sometimes grow deeper before they become obvious on the surface.
The role of chronic inflammation in malignant change
Chronic inflammation is a known driver of cellular mutations and can contribute to the development of skin cancer in previously injured areas. Conditions that cause long-term skin irritation, such as chronic ulcers or persistent infections, create a state of constant cellular turnover. The more frequently cells have to divide to repair damage, the higher the statistical probability that a genetic error will occur.
NICE clinical guidelines suggest that any area of the skin affected by chronic inflammation or non-healing wounds should be monitored closely for signs of malignancy. This is why individuals with long-term issues like leg ulcers are often reviewed regularly by dermatology or wound care specialists. Identifying a malignant change early in these complex environments is essential for preventing extensive local tissue destruction and ensuring that the appropriate surgical treatment can be performed.
Understanding the Marjolin ulcer phenomenon
A Marjolin ulcer is a specific type of skin cancer that arises in an area of chronic scarring or long-standing skin irritation. While this term is most commonly associated with squamous cell carcinoma, basal cell carcinoma can also present in this manner. These ulcers are typically found in scars from severe burns, chronic bone infections, or old vaccination sites. They are characterised by their persistent nature and a failure to respond to conventional treatments for wound healing.
The clinical presentation often involves a slow-growing, painless ulcer with firm, raised edges. Because the cancer is growing within dense scar tissue, it can be more locally aggressive than a typical sun-induced basal cell carcinoma. Early identification of a Marjolin ulcer is vital, as the treatment may involve more extensive surgery to ensure that all the abnormal cells and the surrounding scar tissue are completely removed. This highlights the importance of never ignoring a change in a decades-old scar.
Challenges in diagnosing cancer in injured skin
One of the greatest challenges for clinicians is distinguishing between a normal evolution of a scar and the development of a skin cancer. Scar tissue can naturally become firmer or change colour over time as it matures. Furthermore, the lack of typical pearly or translucent features in scar-related tumours can lead to a delayed diagnosis. Many patients do not seek help because they assume the changes are simply related to their old injury.
To improve detection, healthcare professionals recommend that individuals perform a monthly check of any significant scars they have. Using a hand-held mirror or asking a partner to help can ensure that even difficult-to-see areas are monitored. You should look for any new lumps, a change in the scar’s firmness, or any areas that have started to bleed or scab repeatedly. If you have any doubt about a change in a scar, your General Practitioner can perform an initial assessment and refer you to a specialist if necessary.
Conclusion
Basal cell carcinoma can develop in scars or previously injured skin due to chronic inflammation and altered cellular environments. These lesions often present as subtle changes in the texture of a scar or as a non-healing ulcer within old injury sites. Because diagnosis in these areas can be challenging, any evolution in a stable scar should be reviewed by a medical professional to ensure early and effective treatment.
If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Can a BCC develop in a childhood vaccination scar?
Yes, while rare, there have been recorded cases of basal cell carcinoma developing in old vaccination scars several decades after the initial injection.
Does every scar have a risk of turning into cancer?
No, the vast majority of scars will never become cancerous; the risk is generally limited to significant scars from burns, chronic ulcers, or high-dose radiation.
What is the first sign of cancer in an old scar?
The first sign is often a change in the scars texture, such as a new firm lump or an area that starts to break down and bleed.
How long does it take for cancer to grow in a scar?
It typically takes many years or even decades for a malignancy to develop within an area of old skin trauma or scarring.
Are burn scars more likely to get BCC?
Severe burn scars, especially those that were slow to heal or have remained fragile, have a higher risk of developing skin cancer compared to simple surgical scars.
Can radiotherapy scars lead to BCC?
Yes, skin that has been treated with radiotherapy for other cancers is at a higher risk of developing basal cell carcinoma many years later.
How do doctors treat a BCC in a scar?
The most common treatment is surgical excision to remove the cancer and a margin of the surrounding tissue to ensure a complete cure.
Authority Snapshot (E-E-A-T)
This article is designed to provide clear and factual information regarding skin health for the general public. The content is written by the Medical Content Team and has been reviewed by Dr. Stefan Petrov. He is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.
